INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "PROCESS OF PREPARING REMIBRUTINIB SUBSTANTIALLY FREE OF NITROSAMINE IMPURITY"

GENEVA, Oct. 15 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2025/053341) for "PROCESS OF PREPARING REMIBRUTINIB SUBSTANTIALLY FREE OF NITROSAMINE IMPURITY" on Mar 31, 2025. With publication no. WO/2025/210469, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CAILLET, Alexandre (Novartis Pharma AGLichtstrasse 354056 Basel), CESAR, JoZko (Novartis farmacevtska proizvodnja d.o.o. Verovskova ulica 571000 Ljubljana), KLANG, Thorsten (Novartis Pharma AGLichtstrasse 354056 Basel), KORDIKOWSKI, And...